India, Aug. 6 -- Most companies talk about scaling up their business, but few can point to a specific number showing how much bigger the opportunity itself has become. This quarter, one pharma player did exactly that, backing a record set of financials with a clear signal that its next phase of spending will look nothing like the last one.

With a market capitalization of around Rs. 27,965 crore, shares of Neuland Laboratories Limited were trading near Rs. 22,184 apiece, and the stock hit a 52-week high today, with a P/E of about 56. The stock climbed 10% after the results were announced.

Ace investor Mukul Agrawal holds a 3.12% stake & Vijay Kedia also holds a 1.01% stake in the company, signaling that the company's growth thesis has at...